Protein Discovery raises $10 million in equity financing

The investment was led by Sante Ventures and was joined by previous investors, including Memphis Biomed Ventures, the Southern Appalachian Fund, and the Nashville Capital Network. Protein Discovery will use the funds to boost market entry activities of its flagship product, the Passport 1200 Sample Prep System.

The Passport System is used to prepare clinically relevant biological samples for analysis by mass spectrometry. Up to 96 samples can be prepared for analysis in less than an hour, compared to days using existing techniques.

Chuck Witkowski, president and CEO of Protein Discovery, said: “By directing our efforts toward simplifying the process, we aim to allow mass spectrometry to grow steadily into exciting high-volume clinical applications.”